Last reviewed · How we verify

NCT05184608

Cycling Dual-task in Parkinson's Disease

Completed NA Last updated 25 May 2022
What this trial tests

NA trial testing Cycling exercise in Parkinson Disease in 15 participants. Completed in 31 January 2022.

Timeline
11 October 2021
Primary endpoint
28 October 2021
31 January 2022

Quick facts

Lead sponsorUniversity of Vigo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment15
Start date11 October 2021
Primary completion28 October 2021
Estimated completion31 January 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Vigo

Who can join

Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of Cycling Dual-Task on Cognitive and Physical Function in Parkinson's Disease: A Randomized Double-Blind Pilot Study.
    Pereira-Pedro KP, de Oliveira IM, Mollinedo-Cardalda I, Cancela-Carral JM. · · 2022 · cited 11× · PMID 35805505 · DOI 10.3390/ijerph19137847

Verify or expand the search:

Other trials of Cycling exercise

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other University of Vigo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05184608.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing